Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Cell Surface CXCR4 and BTK Expression Are Associated in Myeloma Cells and Osteoclast Precursors and Mediate Myeloma Cell Homing and Clonogenicity, and Osteoclastogenesis

Rakesh Bam, Wen Ling, Sharmin Khan, Angela Pennisi, MD, Sathisha Upparahalli Venkateshaiah, PhD, Xin Li, PhD, Ryan Williams, Frits van Rhee, MD, PhD, Bijay Nair, MD, Saad Usmani, MD, FACP, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2011) 118 (21): 884.

https://doi.org/10.1182/blood.V118.21.884.884

Published: 2011

Journal Articles

Systemically Injected Mesenchymal Stem Cells Traffic to Myelomatous Bone and Inhibit Bone Disease, and Intralesionally Promotes Bone Formation and Delays Myeloma Progression During the Disease Active Stage or Remission

Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Yuping Wang, PhD, Angela Pennisi, MD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr, PhD, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 980.

https://doi.org/10.1182/blood.V116.21.980.980

Published: 2010

Journal Articles

Human Placenta-Derived Adherent Cells Delivered Intralesionally Inhibit Myeloma Bone Disease and Tumor Growth, While Intravenously Are Capable of Trafficking to Myelomatous Bone.

Xin Li, PhD, Wen Ling, MS, Angela Pennisi, MD, Yuping Wang, PhD, Sharmin Khan, MS, Mohammad Heidaran, PhD, Ajai Pal, PhD, Xiaokui Zhang, PhD, Shuyang He, PhD, Andy Zeitlin, Stewart Abbot, PhD, Herbert Faleck, DO, Robert Hariri, MD, PhD., John Shaughnessy, Jr., PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, MPH, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 3717.

https://doi.org/10.1182/blood.V116.21.3717.3717

Published: 2010

Journal Articles

Consequences of Intermittent PTH Treatment on Myeloma Growth, Bone Disease and Molecular Profiling of Whole Myelomatous Bone

Angela Pennisi, MD, Xin Li, PhD, Bart Barlogie, M.D., Ph.D., John Shaughnessy PhD, Jr., Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 4063.

https://doi.org/10.1182/blood.V116.21.4063.4063

Published: 2010

Journal Articles

Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease

Rakesh Bam, Angela Pennisi, MD, Xin Li, PhD, Sharmin Khan, MS, Yuping Wang, Ph.D., Wen Ling, MS, Bart Barlogie, M.D., Ph.D., John Shaughnessy, Jr., PhD, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 447.

https://doi.org/10.1182/blood.V116.21.447.447

Published: 2010

Journal Articles

Systemically Transplanted Human Bone Marrow Mesenchymal Stem Cells Primarily Traffic to Mesenteric Lymph Nodes

Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Yuping Wang, Ph.D., Angela Pennisi, MD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 2580.

https://doi.org/10.1182/blood.V116.21.2580.2580

Published: 2010

Journal Articles

Exploitation of Novel Hyperdiploid and Nonhyperdiploid Myeloma Cell Lines for Studying Innovative Interventions for Myeloma and Its Associated Bone Disease.

Angela Pennisi, MD, Xin Li, PhD, Maurizio Zangari, MD, Jeffrey R. Sawyer, MD, Fenghuang Zhan, MD, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, PhD, Shmuel Yaccoby, PhD

Blood (2007) 110 (11): 548.

https://doi.org/10.1182/blood.V110.11.548.548

Published: 2007

Journal Articles

Sphingosine-1 Phosphate (S1P) Is a Myeloma Survival Factor and Protects Myeloma Cells from Thalidomide-Induced Growth Inhibition by Counteracting Ceramide Activity.

Xin Li, PhD, Angela Pennisi, MD, Shmuel Yaccoby, PhD

Blood (2007) 110 (11): 3509.

https://doi.org/10.1182/blood.V110.11.3509.3509

Published: 2007

Journal Articles

Inhibitors of Fibroblast Activation Protein (FAP) Inhibit Primary Myeloma Growth and Osteoclastogenesis Ex Vivo and In Vivo.

Angela Pennisi, MD, Xin Li, PhD, Dana Gaddy, PhD, Nisreen Akel, Nazneen Aziz, PhD, Shmuel Yaccoby, PhD

Blood (2007) 110 (11): 813.

https://doi.org/10.1182/blood.V110.11.813.813

Published: 2007

Journal Articles

Small Leucine-Rich Proteoglycans (SLRPs) Are Involved in the Anti-Myeloma Response of Osteoblasts.

Xin Li, PhD, Angela Pennisi, MD, Shmuel Yaccoby

Blood (2007) 110 (11): 815.

https://doi.org/10.1182/blood.V110.11.815.815

Published: 2007

Journal Articles

Atacicept (TACI-Ig) Inhibits Growth of TACI high Primary Myeloma Cells in SCID-Hu Mice.

Shmuel Yaccoby, PhD, Stacey R. Dillon, PhD, Wen Ling, Paul Perkins, John R. Tisdale, Angela Pennisi, MD, Rinku Saha, Xin Li, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, Fenghuang Zhan, MD, PhD, John Shaughnessy, PhD

Blood (2006) 108 (11): 842.

https://doi.org/10.1182/blood.V108.11.842.842

Published: 2006

Journal Articles

PTH and Bortezomib Suppress Growth of Primary Human Myeloma through Increased Bone Formation In Vivo.

Angela Pennisi, MD, Wen Ling, Paul Perkins, Rinku Saha, Xin Li, Bart Barlogie, MD, PhD, Guido Tricot, MD, Maurizio Zangari, MD, Shmuel Yaccoby, PhD

Blood (2006) 108 (11): 509.

https://doi.org/10.1182/blood.V108.11.509.509

Published: 2006

NARROW

Cell Surface CXCR4 and BTK Expression Are Associated in Myeloma Cells and Osteoclast Precursors and Mediate Myeloma Cell Homing and Clonogenicity, and Osteoclastogenesis

Systemically Injected Mesenchymal Stem Cells Traffic to Myelomatous Bone and Inhibit Bone Disease, and Intralesionally Promotes Bone Formation and Delays Myeloma Progression During the Disease Active Stage or Remission

Human Placenta-Derived Adherent Cells Delivered Intralesionally Inhibit Myeloma Bone Disease and Tumor Growth, While Intravenously Are Capable of Trafficking to Myelomatous Bone.

Consequences of Intermittent PTH Treatment on Myeloma Growth, Bone Disease and Molecular Profiling of Whole Myelomatous Bone

Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease

Systemically Transplanted Human Bone Marrow Mesenchymal Stem Cells Primarily Traffic to Mesenteric Lymph Nodes

Exploitation of Novel Hyperdiploid and Nonhyperdiploid Myeloma Cell Lines for Studying Innovative Interventions for Myeloma and Its Associated Bone Disease.

Sphingosine-1 Phosphate (S1P) Is a Myeloma Survival Factor and Protects Myeloma Cells from Thalidomide-Induced Growth Inhibition by Counteracting Ceramide Activity.

Inhibitors of Fibroblast Activation Protein (FAP) Inhibit Primary Myeloma Growth and Osteoclastogenesis Ex Vivo and In Vivo.

Small Leucine-Rich Proteoglycans (SLRPs) Are Involved in the Anti-Myeloma Response of Osteoblasts.

Atacicept (TACI-Ig) Inhibits Growth of TACI high Primary Myeloma Cells in SCID-Hu Mice.

PTH and Bortezomib Suppress Growth of Primary Human Myeloma through Increased Bone Formation In Vivo.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only